<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Afirma GEC":1,
"ectopic parathyroid":1,
"fine-needle aspiration":6,
"thyroid":37,
"lncRNA":5,
"miRNA":2,
"ncRNA":1,
"transcription":1,
"translation":1,
"Breast cancer":23,
"Chemoresistance":3,
"MVP":1,
"Notch signaling pathway":2,
"Apoptosis":14,
"Invasion":12,
"Papillary thyroid cancer":19,
"Proliferation":16,
"ZNF703":1,
"siRNA":1,
"Cancer survivor":1,
"Estrogen replacement":1,
"Estrogen-progestin replacement":1,
"Gynecologic cancer":1,
"HRT":1,
"Hormone replacement therapy":1,
"MHT":1,
"Menopausal hormone therapy":1,
"Non-gynecologic cancer":1,
"Oncologic patient":1,
"Recurrence risk":1,
"Milan system":1,
"cytopathology":3,
"salivary gland":1,
"Endoscopic thyroidectomy":7,
"Papillary thyroid carcinoma":65,
"Robotic thyroidectomy":2,
"Laparoscopic ablation":1,
"Laparoscopic surgery":1,
"Liver resection":1,
"Local tumor control":1,
"Thyroid carcinoma":17,
"independent risk factor":1,
"survival":8,
"thyroid lobectomy":3,
"total thyroidectomy":2,
"equine endocrinology":1,
"horse":1,
"parathyroid adenoma":3,
"parathyroid imaging":1,
"parathyroidectomy":1,
"technetium Tc 99m sestamibi scan":1,
"Head and neck squamous cell carcinoma":2,
"Nasopharyngeal carcinoma":4,
"Oral squamous cell carcinoma":2,
"Radiotherapy":3,
"Secondary squamous cell carcinoma":1,
"Dissemination":1,
"Recurrence on the incision":1,
"Tumour seeding":1,
"Follicular adenoma":1,
"Follicular neoplasm":2,
"Follicular thyroid carcinoma":3,
"Thyroid cancer":75,
"Thyroid gland":4,
"Ultrasonography":14,
"contrast-enhanced ultrasound":4,
"lymph node metastasis":8,
"ultrasound":8,
"Merkel cell carcinoma":1,
"SATB2":1,
"differential diagnosis":2,
"immunohistochemistry":13,
"neuroendocrine":3,
"site of origin":1,
"transcription factor":1,
"Interstitial laser photocoagulation":1,
"Therapeutic outcome":1,
"Thyroid nodule":19,
"Graves’ disease":3,
"Graves’ orbitopathy":1,
"Outcome":2,
"Radioiodine":2,
"TSH-receptor antibody":1,
"Thyroidectomy":24,
"Areola approach":1,
"Central neck dissection":3,
"Safety":2,
"Trauma":1,
"Vestibular approach":1,
"Chemotherapy":7,
"Interstitial pneumonitis":1,
"Pegylated liposomal doxorubicin":1,
"hsa-miR139-5p and HNRNPF":1,
"miRNome sequencing":1,
"stroma infiltration":1,
"Antiemetics":1,
"Chemotherapy-induced nausea and vomiting":1,
"Guideline":3,
"Differentiated thyroid carcinoma":17,
"N1b":1,
"Prognostic value":1,
"TNM-7":1,
"TNM-8":1,
"CLT":1,
"Cancer":16,
"Hashimoto's":2,
"Incidental":1,
"ACR TI-RADS":1,
"ATA guidelines":1,
"thyroid nodules":12,
"Atypia of undetermined significance":3,
"Chronic lymphocytic thyroiditis":1,
"Thyroid malignancy":1,
"Thyroiditis":2,
"Chin numbness":1,
"Lip numbness":1,
"Mental nerve":1,
"Nerve injury":1,
"Thyroid surgery":3,
"Transoral endoscopic thyroidectomy":1,
"Graves' disease":2,
"Hyperthyroidism":5,
"Toxic multinodular goiter":1,
"Toxic solitary nodule":1,
"adjuvant":1,
"adverse effects":1,
"breast neoplasms":2,
"heart diseases":1,
"survivorship":1,
"Dihydroxyphenylalanine":1,
"Fluorodeoxyglucose":1,
"Medullary thyroid carcinoma":14,
"PET/CT":3,
"Somatostatin":1,
"cribriform-morular variant of papillary thyroid carcinoma":1,
"cytology":7,
"diagnosis":8,
"lung metastasis":1,
"APC":2,
"Gardner syndrome":1,
"WNT":3,
"familial adenomatosis polyposis":1,
"medulloblastoma":1,
"administrative database":1,
"epidemiology":5,
"gestational diabetes":1,
"pregnancy":1,
"Denosumab":2,
"Fibroblast growth factor 23 (FGF-23)":1,
"Hypercalcemia":2,
"Zoledronic acid":1,
"acid-base homeostasis":1,
"ion transporters":1,
"physiological and pathophysiological role":1,
"Pentose phosphate pathway":1,
"Reactive oxygen species":1,
"frail elderly":1,
"frailty":1,
"geriatric assessment":1,
"geriatric oncology":1,
"head and neck cancer":4,
"quality of life":4,
"Hashimoto":1,
"Lymphoma":4,
"MALT":1,
"Anti-cancer therapeutics":1,
"Mouse model":1,
"Preclinical testing":1,
"anaplastic thyroid cancer":3,
"chemoradiation":1,
"external beam radiotherapy":1,
"multimodality":1,
"radiation":5,
"trimodality":1,
"undifferentiated thyroid cancer":1,
"Epithelia-lmesenchymal transition (EMT)":1,
"Prostate cancer":3,
"circFoxo3":1,
"incidentaloma":1,
"overdiagnosis":1,
"screening":2,
"Lenvatinib":5,
"preclinical studies":1,
"tyrosine kinase inhibitor":3,
"Bethesda system":2,
"Thyroid aspiration cytology":1,
"cyst fluid only":1,
"foamy cells":1,
"Circular RNA":3,
"RAPGEF5":1,
"TXNIP":1,
"miR-27a-3p":1,
"miRNA sponge":1,
"matrix metalloproteinases-1":1,
"matrix metalloproteinases-2":1,
"neck dissection":4,
"tissue inhibitor of metalloproteinases-1":1,
"tissue inhibitor of metalloproteinases-2":1,
"Cordectomy":1,
"Difficult exposure":1,
"Glottic cancer":1,
"Glottoplasty":1,
"Laser":1,
"Thyroplasty":1,
"DCIS":1,
"Duct abnormalities":1,
"Non-mass abnormalities":1,
"Clinical behaviors":1,
"DTC":2,
"FTC":1,
"PTC":7,
"TERT":4,
"lymph node ratio":1,
"lymph node yield":2,
"persistent thyroid cancer":1,
"surgical quality":1,
"Papillary thyroid carcinoma (PTC)":4,
"SOCS1":1,
"STAT3 activation":1,
"TRIM14":1,
"fine-needle aspiration biopsy":4,
"histopathology":3,
"radioactive iodine":3,
"classification":3,
"malignancy":5,
"microRNA":5,
"mutation analysis":1,
"LncRNA FOXD3-AS1":1,
"MiR-296-5p":1,
"Mobility":1,
"SOX2":1,
"circ_0005273":1,
"miR-1183":1,
"progression":4,
"Thy terminology":1,
"United Kingdom":1,
"meta-analysis":4,
"risk of malignancy":2,
"thyroid fine-needle aspiration cytology (FNAC)":1,
"Molecular testing":2,
"Oncocytic variant":1,
"HOXA11-AS":1,
"YBX2":1,
"miR-98-5p":1,
"Frozen section":1,
"Thyroid neoplasm":4,
"eta-analysis":1,
"Endocrinology":1,
"Nuclear medicine":1,
"PET":2,
"Predictive":1,
"Prognostic":1,
"Inflammatory response":1,
"Oxidative stress":2,
"PTPN2":1,
"Hürthle cell":1,
"atypia of undetermined significance (AUS)":2,
"fine-needle aspiration (FNA)":3,
"follicular lesion of undetermined significance (FLUS)":2,
"malignancy risk":1,
"multinodularity":1,
"Japan":1,
"Multivariate statistical method":1,
"New hotspot panel":1,
"Next generation sequencing":1,
"Risk score":1,
"Anaplastic thyroid carcinoma":12,
"Antiangiogenesis":1,
"Bevacizumab":1,
"Mitochondrial targeting":1,
"Phase-transformation":1,
"Sequential targeting":1,
"Cell vitality":1,
"EMT":6,
"GCGR":1,
"P38/ERK":1,
"Machine learning":2,
"Magnetic resonance imaging":4,
"Radiomics":1,
"GPER":1,
"GPER1":1,
"GPR30":1,
"Active surveillance":4,
"BRAF V600E mutation":1,
"Papillary thyroid microcarcinoma":4,
"Prognosis":25,
"Risk stratification":3,
"Family cancer history":1,
"head neck squamous cell carcinoma":2,
"matched-pair study":1,
"tongue squamous cell carcinoma":1,
"autoimmunity":1,
"thyroid hormone":5,
"thyroid hormone metabolism and transport":1,
"thyroid hormone receptors":1,
"clinical practice guidelines":1,
"survey":1,
"T3b":1,
"extrathyroidal extension":3,
"papillary thyroid carcinomas":1,
"prognostic factors":2,
"Fukushima Daiichi Nuclear Power Plant accident":1,
"Fukushima Health Management Survey":1,
"thyroid ultrasound examination":1,
"bioinformatics":4,
"data mining":1,
"endocrine surgery":1,
"intraoperative nerve monitoring":1,
"recurrent laryngeal nerve":2,
"risk factor":3,
"surgery":5,
"radioiodine therapy":2,
"thyroid radioactive iodine uptake":1,
"LAG3":1,
"PD-1":1,
"Synergistic inhibition":1,
"Triple-negative breast cancer":1,
"Tumour infiltrating lymphocytes":1,
"ERK pathway":1,
"MEK-ERK inhibitor":1,
"Selenium":2,
"U0126":1,
"thyroid adenoma":1,
"thyroid neoplasms":14,
"thyroid stimulating hormone":1,
"thyrotropin":2,
"Forkhead box transcription factor M1":1,
"migration":10,
"thyroid papillary carcinoma":1,
"integrated analysis":1,
"key genes":1,
"microarray":2,
"CD24":1,
"CD44":1,
"cancer stem cell":1,
"BRAF mutation":3,
"recurrence":7,
"Akt/mammalian target of rapamycin signaling":1,
"medullary thyroid cancer":4,
"zinc finger protein 703":1,
"cyclin-dependent kinase":1,
"long noncoding RNA 00511":1,
"Chemosensitivity":1,
"Exosome":3,
"Hepatocellular carcinoma":5,
"Mesenchymal stem cell":1,
"miR-199a-3p":1,
"False-negative":1,
"False-positive":1,
"Fine-needle aspiration cytology (FNAC)":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"2A típusú multiplex endokrin neoplasia szindróma":1,
"genetic testing":1,
"genetikai vizsgálat":1,
"medullaris pajzsmirigydaganat":1,
"multiple endocrine neoplasia type 2A":1,
"phaeochromocytoma":1,
"primary hyperparathyroidism":1,
"primer hyperparathyreosis":1,
"miR-383-5p":1,
"Korea":1,
"occupations":1,
"socioeconomic factors":1,
"NEK kinase family":1,
"NEK1":1,
"NEK3":1,
"NEK5":1,
"Tissue mirco array":1,
"Metformin":2,
"NSCLC":1,
"Snail":1,
"YAP":1,
"miR-381":1,
"Auto-fluorescence":1,
"Near-infrared":1,
"Parathyroid":2,
"NF-κB pathway":1,
"miR-145":1,
"progression-free survival":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"CdTe":1,
"Coded aperture":1,
"Compact gamma camera":1,
"Medipix2":1,
"Radioguided surgery":1,
"Timepix":1,
"Guidelines":2,
"Size threshold":1,
"Thyroid imaging reporting and data system":1,
"Adrenal insufficiency":1,
"Adrenocorticotropic hormone deficiency":1,
"Immunotherapy":6,
"Pembrolizumab":2,
"Programmed cell death 1":1,
"Chromogenic Multiplex immunohistochemistry":1,
"Chromogenic quadruplex for NSCLC diagnostics":1,
"Non-small cell Lung carcinoma (NSCLC)":1,
"CNV":1,
"TCGA":1,
"prognostic markers":1,
"RCC":2,
"WHO":1,
"klasszifikáció":1,
"renal cell carcinoma":2,
"vesesejtes carcinoma":1,
"Intensity modulated proton therapy":1,
"Lymphoma cancer":1,
"NTCP":1,
"RapidArc":1,
"Seconday cancer risk estimate":1,
"VMAT":1,
"IODINE RADIOISOTOPES":1,
"MODELS, ECONOMIC":1,
"SORAFENIB":3,
"SYSTEMATIC REVIEW":1,
"THERAPEUTIC USE":1,
"Braf":5,
"Capsular invasion":1,
"Cáncer de tiroides":2,
"Inmunohistoquímica":1,
"Invasión capsular":1,
"Invasión vascular":1,
"Molecular pathology":1,
"Non-invasive follicular tumor with papillary-like nuclear features":1,
"Patología molecular":1,
"RAS":3,
"TP53":2,
"Tumor folicular no invasivo con rasgos nucleares de tipo papilar":1,
"Vascular invasion":1,
"AhR":1,
"SLUG":1,
"cell migration and invasiveness":1,
"STAT3":3,
"cancer stem cells":1,
"cell proliferation":4,
"cisplatin":2,
"curcumin":2,
"Level VII":1,
"Lymph node dissection":1,
"Video-assisted approach":1,
"Thymic enlargement":1,
"Thymus":1,
"Thyroglobulin":8,
"Thyroid follicular tumor":1,
"True thymic hyperplasia":1,
"14-3-3 ε/γ":1,
"Adaptor protein":1,
"Cell growth":2,
"LNK":1,
"Joinpoint regression analysis":1,
"histology":2,
"incidence":2,
"mortality":2,
"net survival":1,
"population-based study":1,
"registries":2,
"survival analysis":1,
"trends":1,
"functional screening":1,
"non-oncogene addiction":1,
"non-oncogenes":1,
"therapeutic targets":1,
"tumor vulnerabilities":1,
"Membrane-based liquid-based preparation technique":1,
"Sedimentation liquid-based preparation technique":1,
"Thyroid fine needle aspiration cytology (FNAC)":1,
"131I radioiodine":1,
"differentiated thyroid cancer":6,
"over and underestimated values":1,
"radiation absorbed dose":1,
"C634R":1,
"RET gene mutation":1,
"type 2 multiple endocrine neoplasia":1,
"False-positive finding":1,
"iodine-131":1,
"radioiodine scintigraphy":1,
"radioiodine single-photon emission computed tomography/computed tomography":1,
"retroperitoneal cysts":1,
"BRAF V600E":3,
"I -131 treatment":1,
"Thyroid function":1,
"ARID1A mutation":1,
"BRCA1 mutation":1,
"Glioblastoma":1,
"Metastasis":5,
"Mismatch repair deficiency":1,
"Temozolomide":1,
"Treatment resistance":1,
"papillary carcinoma prognosis":1,
"papillary microcarcinoma":2,
"thyroid capsule":1,
"tumor diameter":1,
"tumor location":1,
"tumor origin":1,
"Biopsy, Fine-Needle":2,
"Core needle biopsy":1,
"Case report":3,
"Hepatic metastases":1,
"Neuroendocrine tumor":2,
"Treatment":3,
"Circ-VRK1":1,
"cell activities":1,
"clinicopathological features":1,
"SMAC/DIABLO":1,
"TUSC2":1,
"Hashimoto’s thyroiditis":1,
"IgG":1,
"N-glycosylation":1,
"antibody-dependent cell-mediated cytotoxicity (ADCC)":1,
"complement-dependent cyttoxicity (CDC)":1,
"sialylation":1,
"environmental exposure":1,
"thyroid health":1,
"uranium":1,
"Papillary carcinoma":5,
"Solid variant":1,
"Anatomical variations":1,
"Carcinome nasopharyngé":1,
"Dosimetry":1,
"Dosimétrie":1,
"Glandes":1,
"Glands":1,
"Intensity modulated radiation therapy":1,
"Modifications anatomiques":1,
"Radiothérapie conformationnelle avec modulation d’intensité":1,
"Endoscopy":1,
"Scarring":1,
"DNA methylation":3,
"biomarkers":4,
"long non-coding RNAs":1,
"Glycolysis":2,
"HIF-1α":1,
"PKM2":1,
"PPAR-γ":1,
"Simvastatin":1,
"Sorafenib resistance":1,
"SPECT/CT imaging":1,
"antisense therapy":1,
"diagnosis and treatment integration":1,
"WT1-AS":1,
"miR-203":1,
"survivin":1,
"combretastatin A4 phosphate (CA4P)":1,
"contrast agents (CAs)":1,
"hepatocellular carcinoma (HCC)":1,
"imaging biomarker":1,
"liver cancer":1,
"magnetic resonance imaging (MRI)":1,
"therapeutic response":1,
"vascular disrupting agents (VDAs)":1,
"computed tomography":2,
"fine needle aspiration cytology":2,
"focus number":1,
"predictivity":1,
"3q26":1,
"GWAS":2,
"LRRC34":1,
"RANBP1":1,
"extension of thyroidectomy":1,
"personalised medicine":1,
"thyroid lobectomy (TL)":1,
"total thyroidectomy (TT)":1,
"Anaplastic thyroid cancer (ATC)":1,
"in vitro studies":1,
"in vivo studies":1,
"molecular pathways":2,
"targeted drugs":1,
"Intraoperative neuromonitoring":1,
"recurrent laryngeal nerve (RLN)":1,
"vocal cord palsy":1,
"Follicular carcinoma":1,
"follicular microcarcinoma":1,
"follicular tumor":1,
"RET":2,
"cysteine":1,
"peptide":1,
"Hashimoto thyroiditis":3,
"Marginal zone B-cell lymphoma":1,
"Mucosa-associated lymphoid tissue":1,
"genomics":1,
"mRNA":1,
"thyroid incidentalomas":1,
"Goiter":1,
"point of care":1,
"thyroid ultrasound":1,
"Grade Groups":1,
"pathological T stage":1,
"prostatectomy":1,
"thyroid hormones":1,
"triiodothyronine":1,
"tumor percentage involvement":1,
"young adults":1,
"Central lymph node dissection":2,
"Prophylactic":1,
"PROX1":1,
"lymphatic factors":1,
"thyroid cancers":1,
"detection rates":1,
"influencing factors":1,
"collision tumor":1,
"follicular thyroid cancer":2,
"FGF5":1,
"miR-188-5p":1,
"Biopsy":2,
"DICER1 protein":1,
"Epithelial neoplasm":1,
"Fine-needle":1,
"Human":1,
"Teratoma":1,
"Outcome modelling":1,
"Secondary malignancies":1,
"Knock-in":1,
"Transgenic mouse model":1,
"c-Myc":1,
"CSCC":1,
"PDCD5":1,
"miR-766":1,
"ceramide":1,
"glucosylceramide":1,
"motility":1,
"Nivolumab":2,
"immune checkpoint inhibitor":1,
"metastatic thyroid cancer":1,
"papillary thyroid":1,
"partial response":1,
"fine-needle aspiration cytology":3,
"rhabdoid phenotype":1,
"Hypocalcemia":2,
"Postoperative Complications":1,
"conventional ultrasound":1,
"petal-like calcifications":1,
"Conventional open thyroidectomy":1,
"Propensity score matching":4,
"Robotic-assisted thyroidectomy":1,
"BRAF inhibitor":1,
"MEK inhibitor":1,
"TERT promoter mutation":2,
"Child":2,
"Parathyroid carcinoma":2,
"Positron emission tomography of methionine":1,
"high-volume":1,
"ipsilateral prophylactic central lymph node dissection":1,
"lateral lymph node dissection":1,
"lymph node metastases":1,
"lymph nodes posterior to the right recurrent laryngeal nerve":2,
"prophylactic lymph node dissection":1,
"thyroid surgeon":1,
"GOLPH3":1,
"LINC00657":1,
"breast carcinoma":1,
"miR-590-3p":1,
"distant metastases":2,
"gene expression profile":1,
"Second lung cancer":1,
"Differentiated":1,
"TSH-releasing hormone":1,
"inappropriate secretion of thyroid-stimulating hormone":1,
"mixed gangliocytoma-adenoma":1,
"neuroendocrine neoplasm":1,
"pituitary gangliocytoma":1,
"thyroid-stimulating hormone":2,
"COVID-19":2,
"Epicenter":1,
"Psychological status":1,
"anlotinib":1,
"clinical trial":1,
"receptor tyrosine kinase inhibitor":1,
"safety management":1,
"vascular endothelial growth factor receptor":1,
"FDG-PET/CT scan":1,
"lung adenocarcinoma":3,
"metastatic carcinoma":2,
"JAK3":1,
"Next-generation sequencing":1,
"RAS mutation":1,
"Struma ovarii":3,
"Capsaicin":1,
"Mitochondrial calcium overload":1,
"TRPV1":1,
"Martinique Principles":1,
"Recommendations":1,
"RFS":1,
"TPC":1,
"nomogram":3,
"signature":2,
"Image interpretation":1,
"Mediastinum":1,
"Neoplasm":2,
"Multifocality":1,
"Recurrence-free survival":2,
"Benfluralin":1,
"Human relevance":1,
"Phenobarbital":1,
"Thyroid MOA":1,
"Thyroid carcinogenicity":1,
"Frozen section examination":1,
"Personalized medicine":2,
"Personalized surgery":1,
"thyroglossal cyst":1,
"thyroglossal duct cyst carcinoma":1,
"Psammoma Bodies":2,
"chemical composition":1,
"pathological micro-calcifications":1,
"glottic morphology":1,
"laryngeal function reconstruction":1,
"partial laryngectomy":1,
"pedicled sternohyoid muscle flap":1,
"spiral CT":1,
"SOX18":1,
"β-catenin":2,
"Psoriasis":1,
"anti TNF α agents":1,
"granuloma annulare":1,
"paradoxical reaction":1,
"Advanced thyroid cancer":1,
"Cutaneous metastases":1,
"Electrochemotherapy":1,
"Copy number variations":1,
"HCC":2,
"PRL-3":1,
"Phosphatase":1,
"TGFB1":1,
"I-131":1,
"radioiodine scan":1,
"tumor sink effect":1,
"fine-needle washout":1,
"immunoassays":1,
"rheumatoid factor":1,
"thyroglobulin auto-antibodies":1,
"TBX3":1,
"USP7":1,
"p57(KIP2)":1,
"atrial fibrillation":1,
"GEO":1,
"expression profiling":1,
"protein-protein interaction":2,
"FOXP1":1,
"hsa_circ_104566":1,
"miR-338-3p":1,
"Malignancy degree":1,
"Mir-146b":1,
"Mir-221":1,
"Thyroid carcinoma tissues":1,
"feasibility studies":1,
"forecasting":1,
"lymphatic metastasis":1,
"Pheochromocytoma":1,
"hyperparathyroidism":1,
"early identification":1,
"primary squamous cell carcinoma of the thyroid":1,
"Bethesda classification":1,
"Esophageal cancer":1,
"Intraoperative nerve stimulation":1,
"Mediastinal lymph node dissection":1,
"Postoperative complication":1,
"Recurrent laryngeal nerve palsy":1,
"Thoracoscopic esophagectomy in prone position":1,
"breast cancer risk":1,
"cancer epidemiology":1,
"cancer genetics":1,
"thyroid peroxidase antibodies":1,
"PANDAR":1,
"diagnostic biomarker":1,
"long non-coding RNA":3,
"therapeutic target":1,
"Parapharyngeal space":2,
"TORS":1,
"Transcervical approach":1,
"Transoral approach":1,
"Transoral robotic surgery":1,
"Bipolar":1,
"GCP":1,
"Monopolar":1,
"RFA":1,
"Statement":1,
"Thermoablation":1,
"cervical lymph nodes":2,
"pathology":1,
"Bilateral axillary breast approach":1,
"Modified radical neck dissection":1,
"da Vinci robot":1,
"Medication adherence":1,
"illness perception":1,
"oncology":4,
"personality":1,
"Endoscopic thyroid surgery":1,
"Minimally invasive thyroid surgery":1,
"Remote access thyroid surgery":1,
"Stimulated thyroglobulin":1,
"Transoral thyroidectomy":2,
"Dissecting instruments":1,
"IONM":1,
"Neural monitoring":1,
"TOETVA":2,
"Vagus nerve":1,
"insulin-like growth factor 1 receptor":1,
"linc00210":1,
"miR-195-5p":1,
"NIFTP":5,
"capsule thickness":1,
"encapsulated follicular variant of papillary thyroid carcinoma":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"case-control studies":1,
"obesity":3,
"ATP-binding cassette transporter A9":1,
"hsa_circ_0039411":1,
"metastasis-associated 1":1,
"miR-1179":1,
"miR-1205":1,
"MTC":2,
"ROC curve analysis":1,
"miR-144":1,
"miR-34a":1,
"real-time PCR":1,
"lobectomy":2,
"follicular":2,
"mixed epithelial and stromal tumor":1,
"thyroid-like":1,
"incidence of cancer":1,
"longitudinal study":1,
"quantitative analysis":1,
"sleep deprivation":1,
"CTNNB1":1,
"MALAT1":1,
"miR-124":1,
"rs619586":1,
"biomarker":3,
"transcriptional regulation":1,
"Cavernous sinus syndrome":1,
"Disc edema":1,
"Rathke’s cleft cyst":1,
"cancer risk":1,
"clinical characteristics":1,
"immunomodulators":1,
"inflammatory bowel disease":1,
"multicenter prospective nested case–control study":1,
"New Caledonia":1,
"case-control study":2,
"diet":1,
"inflammation":3,
"ER ɑ":1,
"P53":1,
"SHARPIN":1,
"Ubiquitination":2,
"CASTLE":2,
"Frozen section analysis":1,
"SETTLE":1,
"Hypopharyngeal carcinoma":1,
"Postoperative adjuvant treatment":1,
"Survival outcome":1,
"Benign thyroid adenoma":1,
"Children and adolescents":1,
"Metabolomics":1,
"FSH-secreting pituitary tumor":1,
"Intact parathyroid hormone":1,
"Optimal time point":1,
"Post-thyroidectomy hypocalcemia":1,
"areola breast approach":1,
"transoral vestibular approach":1,
"DNA repair":1,
"clonality":2,
"dedifferentiation":1,
"whole-genome sequencing":2,
"Phthalate":1,
"Urinary metabolites":1,
"learning curve":1,
"Fine needle aspiration":2,
"Hemithyroidectomy":2,
"Indeterminate cytology":3,
"bilateral axillo-breast approach robotic thyroidectomy":1,
"minimally invasive surgery":1,
"transoral robotic thyroidectomy":1,
"(131)I":1,
"Mesoporous alumina":1,
"Radioactive concentration":1,
"Solid phase extraction":1,
"Sorbent":1,
"secondary head and neck cancer reconstruction":1,
"sequential free flap":1,
"HMGA2":1,
"miRNA-98-5p":1,
"papillary&nbsp":1,
"thyroid&nbsp":1,
"carcinoma":7,
"Expression":1,
"LMR":1,
"GATA 3":1,
"TTF-1":4,
"Fine-needle aspirate":1,
"Lymph node":2,
"growth disturbances":1,
"multiple endocrine neoplasia type 2B":1,
"stigmata":1,
"African Americans":1,
"RNA":1,
"epigenomics":1,
"health care disparities":1,
"long noncoding":1,
"microRNAs":1,
"pan-cancer":1,
"Musashi RNA binding protein 2":1,
"microRNA-143-3p":1,
"Adolescent":1,
"PBBs":1,
"PBDEs":1,
"polybrominated biphenyls":1,
"polybrominated diphenyl ethers":1,
"Childhood diseases":1,
"fluorescence imaging":1,
"minimally invasive treatment":1,
"nanoparticle":1,
"photodynamic therapy":1,
"porphyrin":1,
"Carcinoma papilar tiroideo":1,
"Choroidal metastasis":1,
"Metástasis coroidea":1,
"Metástasis ocular":1,
"Ocular metastasis":1,
"SOX15":1,
"miR-147b":1,
"ABO blood group":1,
"Rh factor":1,
"advanced stage":1,
"breast metastasis":2,
"plasmacytoid tumors":1,
"ASCL1":1,
"ChIP-seq":1,
"NKX2-1":1,
"SCLC":1,
"lung cancer":2,
"Feedback loop":1,
"SNHG1":1,
"SP1":1,
"miR-199a-5p":1,
"Individualized treatment":1,
"Radioablation":1,
"methylation markers":1,
"actin":1,
"spheroid":1,
"Cancer registry":1,
"Positive predictive value":1,
"Sensitivity":1,
"Validity":1,
"Drug target":1,
"Heat shock protein":1,
"Diffusion weighted imaging":1,
"breast lesions":1,
"diffusion kurtosis imaging":1,
"pathological subtypes":1,
"PD-L1":3,
"anoectochilus formosanus hayata":1,
"resveratrol":1,
"steroid hormone":1,
"DUSP5":1,
"Differentially expressed gene":1,
"thyroid follicular carcinoma":1,
"7-gene test":1,
"molecular diagnostics":1,
"Epidemiological study characteristics":1,
"Spinal metastases":1,
"Surgical treatment":1,
"Univariate analysis":1,
"CD8(+) T cells":1,
"Neuron":1,
"Neurotransmitter":1,
"p85":1,
"Ablation":1,
"Differentiated thyroid cancer (DTC)":1,
"Low dose":1,
"Radioactive iodine (RAI)":1,
"Radioiodine therapy (RIT)":1,
"surgical assessment":1,
"EGFR mutation":2,
"HNF-4a":1,
"KRAS mutation":1,
"MUC1":1,
"MUC5B":1,
"adenocarcinoma":2,
"lung":1,
"mucin":1,
"MSI":1,
"Mismatch repair":1,
"PDL-1":1,
"Stromal desmoplasia":1,
"ret-mutation":1,
"BRAF(V600E)":1,
"3D CNN":1,
"Cancer tissue detection":1,
"Computer-aided diagnosis":2,
"Deep learning":1,
"Prostate":1,
"Transfer learning":1,
"Sarcopenia":1,
"Gene expression":3,
"RUNX2":1,
"RAP1B":1,
"Twist1/NF-κB pathway":1,
"miR-200b/C":1,
"Cancer survivors":2,
"SEER":4,
"Second primary malignancies":1,
"Blepharospasm":1,
"Focal dystonia":1,
"Calcified lymphadenopathy":1,
"Mimicking":1,
"Silicosis":1,
"abscess":1,
"aneurysm":1,
"astrocytoma":1,
"granular cell tumor":1,
"malignant peripheral nerve sheath tumor":1,
"sellar suprasellar region":1,
"carcinoembryonic antigen":1,
"radioimmunotherapy colorectal cancer":1,
"yttrium-90":1,
"ACR Thyroid Imaging Reporting and Data System (ACR TI-RADS)":1,
"Follicular variant of papillary thyroid carcinoma (FV-PTC)":1,
"TINF2":1,
"familial nonmedullary thyroid cancer":1,
"germline DNA variants":1,
"melanoma":1,
"shelterin":1,
"telomere length":1,
"ITGA7":1,
"epithelial-to-mesenchymal transition (EMT)":1,
"papillary thyroid cancer (PTC)":1,
"Dog":1,
"JAK1":1,
"JAK2":1,
"biopsy, large-core needle":1,
"Multidisciplinary":1,
"Systemic therapy":1,
"Salvage surgery":1,
"age":2,
"distant metastasis":1,
"liquid-based cytology":2,
"quantitative PCR":1,
"CLDN10":1,
"bioinformatics method":1,
"immune cell infiltration":1,
"BRAF 3":1,
"RET/PTC":1,
"heterogeneity":1,
"Bowel preparation":1,
"Oral antibiotics":1,
"Surgical site infection":1,
"Elastography":1,
"Fibrosis":2,
"Shear wave":1,
"Diagnostic performance":2,
"Immune activation":1,
"Histologie des cancers thyroïdiens":1,
"Registre des cancers thyroïdiens":1,
"Thyroid cancer pathology":1,
"Thyroid cancer registry":1,
"Thyroid cancer therapy":1,
"Traitement des cancers thyroïdiens":1,
"Évolution":1,
"18F-fludeoxyglucose positron emission tomography computed tomography":1,
"FDG PET/CT":1,
"TENIS syndrome":1,
"muscle metastasis":1,
"solitary muscle metastasis":1,
"2020":1,
"Adult":1,
"Australia":1,
"Bone pain":1,
"February":1,
"Female":1,
"MRI":1,
"PET scan":1,
"Radionuclide imaging":1,
"Resection of tumour":1,
"TSH":1,
"Thyroxine (T4)":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"White":1,
"Electrocoagulation":1,
"Meticulous dissection technique":1,
"Rehabilitation":1,
"FGFR":1,
"Bethesda":3,
"Bethesda System for Reporting Thyroid Cytopathology":1,
"Carcinome papillaire":1,
"Cytologie":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Néoplasme folliculaire thyroïdien non invasif avec caractéristiques nucléaires du carcinome papillaire (NIFTP)":1,
"Thyroïde":1,
"Échographie":1,
"cancer cachexia":1,
"neutrophil-to-lymphocyte ratio":2,
"squamous cell carcinoma of unknown primary":1,
"carbon nanoparticles":1,
"neck lymph node dissection":1,
"parathyroid glands":1,
"Chernobyl":1,
"Europe":1,
"pediatric thyroid cancer":1,
"reporter microRNAs":1,
"reporter transcription factors":1,
"Deiodinase":1,
"Subclinical hyperthyroidism":2,
"Thyrotoxicosis":1,
"genetic alterations":1,
"Voluntary childlessness":1,
"survivor":1,
"young adult":1,
"Clinical trials":1,
"Combination treatment":1,
"Mouse models":1,
"Synergism":1,
"Gender disparity":1,
"Genetics":2,
"Hormonal status":1,
"Alternative Splicing (AS)":1,
"TCGA database":1,
"head and neck squamous cell carcinoma (HNSCC)":1,
"Surveillance":2,
"and End Results (SEER) Program":1,
"TNM classification":1,
"disease stage":1,
"prognostic index":2,
"ddPCR":1,
"diagnostics":1,
"let-7":1,
"de‐escalation":1,
"immediate surgery":1,
"low risk":1,
"quantitative parameters":1,
"Anaplastic carcinoma":1,
"Diagnostic challenges":1,
"Riedel's thyroiditis":1,
"Thyroid lymphoma":1,
"Thyroid mass":1,
"ENT":1,
"Cartilage":1,
"Hypopharyngeal neoplasms":1,
"Laryngeal neoplasms":2,
"Multislice computed tomography":1,
"germline–somatic designation":1,
"somatic evolution":1,
"tumor sequencing":1,
"molecular classifier":1,
"Neuromonitoring":1,
"surgical technique":1,
"transoral endoscopic thyroidectomy by vestibular approach (TOETVA)":1,
"CISD-1":1,
"CRISPR-Cas12a":1,
"Circulating tumour cells":1,
"H-reflex depression":1,
"Leptospirosis":1,
"Wnt1":1,
"Wnt1 expression":1,
"Wnt1 mutations":1,
"cancers":1,
"co-occurrence":1,
"type XV osteogenesis imperfecta":1,
"thyroglobulin antibodies":1,
"Metastatic lung tumor":1,
"Primary pulmonary meningioma":1,
"Video-assisted thoracoscopic surgery":1,
"behavior":1,
"canine":1,
"luteinizing hormone":1,
"musculoskeletal":1,
"neoplasia":1,
"neuter":1,
"spay":1,
"urinary incontinence":1,
"carcinoid syndrome":1,
"malignant transformation":1,
"mature cystic teratoma":1,
"strumal carcinoid":1,
"Shear wave elastography":1,
"TI-RADS":1,
"Malignant neoplasm":1,
"Second primary cancer":1,
"Smoking-associated cancers":1,
"Surveillance Epidemiology and End Results (SEER) program":1,
"Beck anxiety and depression inventory":1,
"SF-36 quality of life survey":1,
"TSH suppression":1,
"Cancer-specific survival":2,
"Overall survival":2,
"Leukocyte immunoglobulin (Ig)-like receptor subfamily B member 1 (LILRB1)":1,
"(18)F-FDG-PET/CT":1,
"(18)F-FDG-PET/TC":1,
"Biochemical incomplete response":2,
"Carcinoma diferenciado de tiroides":1,
"Indeterminate response":1,
"Respuesta bioquímica incompleta":1,
"Respuesta indeterminada":1,
"hypophosphataemic osteomalacia":1,
"tumour-induced osteomalacia":1,
"EGFR":1,
"Intrathyroid thymic carcinoma (ITTC)":1,
"Thymic carcinoma (TC)":1,
"c-KIT":1,
"NECB":1,
"hyperprolactinemia":1,
"carcinoma showing thymus-like differentiation":1,
"salivary glands":1,
"sublingual gland":1,
"Esophagus":1,
"Monophasic":1,
"SS18-SSX2":1,
"Synovial sarcoma":1,
"Carcinoma de tireoide":1,
"Citologia de punção aspirativa com agulha fina":1,
"Color Doppler ultrasound":1,
"Grayscale ultrasound":1,
"Nódulo maligno suspeito":1,
"Suspicious malignant nodule":1,
"Ultrassonografia com Doppler colorido":1,
"Ultrassonografia em escala de cinza":1,
"strap muscles":1,
"blood biomarkers":1,
"calcium gluconate infusion test":1,
"everolimus":1,
"larynx":1,
"neck":1,
"BRAF K601E":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"thyroid cytology":1,
"PITX1":1,
"bioinformation":1,
"eukaryotic translation initiation factor 5A":1,
"Endoscope":1,
"lacrimal sac carcinoma":1,
"navigation":1,
"Medullary":1,
"Papillary":3,
"TIRADS":1,
"Gold nanoparticles":1,
"Human breast carcinoma":1,
"Methylene orange":1,
"Let-7d":1,
"Long non-coding RNA (lncRNA) DIO3OS":1,
"NF-κB2":1,
"Dynamin-related protein 1":1,
"Mitochondrial dynamics":1,
"Thyroid cancer, Hürthle cell":1,
"Thyroid neoplasms, Oncocytic":1,
"prognostic factor":1,
"Hypothyroidism":3,
"Laryngeal Cancer":1,
"Laryngectomy":1,
"Marine-Lenhart syndrome":1,
"functioning nodule":1,
"DATHYRCA":1,
"Follicular variant of papillary thyroid carcinoma":1,
"Autoantibodies":1,
"Autoantigens":1,
"Thyroid autoimmunity":1,
"Thyroid peroxidase":1,
"DICER1":1,
"DROSHA":1,
"Polymorphism":2,
"XPO5":1,
"Intestine":1,
"Coffee":1,
"dose–response":1,
"Association prediction":1,
"Cosine similarity":1,
"Disease":1,
"Label propagation":1,
"Locality-constrained linear coding":1,
"circRNA":1,
"131I therapy":1,
"nonprivate residence":1,
"radiation safety":1,
"PI3K/AKT":1,
"TGFβ1":1,
"TMEM158":1,
"carcinogenesis":1,
"pancreatic cancer":2,
"non-TNBC":1,
"tRFs":1,
"tumorigenesis":1,
"Endocrine toxicity":1,
"epithelial-mesenchymal transition":2,
"long noncoding RNA SLC26A4-AS1":1,
"mitogen-activated protein kinase pathway":1,
"Hey2":1,
"microRNA-599":1,
"cervical cancer":1,
"lncRNA PTCSC3":1,
"miR-574-5p":1,
"cytochrome P450":1,
"dioxin":1,
"endocrine disruptor":1,
"phenotyping":1,
"management":1,
"microcarcinoma":1,
"observation":1,
"Angiogenesis":1,
"Minigenes":1,
"TR3/Nur77":1,
"Tumor":1,
"shRNA":1,
"endocrine":1,
"head and neck":1,
"Osteoporosis":1,
"Severe osteoporosis":1,
"American thyroid association guidelines":1,
"Afirma":2,
"Gene Expression Classifier":1,
"Genomic Sequencing Classifier":1,
"Breast-axillo approach":1,
"Minimally invasive":1,
"Remote-access":1,
"Robotic":1,
"cognitive function":1,
"depression":1,
"levothyroxine therapy":1,
"CDKN1C gene":1,
"FTIR":1,
"Lymph nodes metastases":1,
"Predictive molecular markers":1,
"Spectroscopy":1,
"Contrast media":1,
"Extracellular space":1,
"Multidetector computed tomography":1,
"Pancreatic ductal carcinoma":1,
"Treatment outcome":2,
"Anaplastic thyroid carcinoma (ATC)":1,
"MRQ-50":2,
"Paired box gene 8 (PAX8)":1,
"Undifferentiated thyroid carcinoma":1,
"BRAFV600E":1,
"Hobnail":1,
"Micro papillary":1,
"Next Generation Sequencing (NGS)":1,
"CLND":1,
"strategies":1,
"Extrathyroid extension":1,
"Dynamic risk stratification":1,
"Napsin A":1,
"Thyroid tumor":1,
"Prophylactic central neck dissection":1,
"Risk factors":3,
"DNA":1,
"FNA":1,
"Suspicious for malignancy":2,
"Radioactive iodine therapy":2,
"Recombinant human thyrotropin":1,
"Response to therapy":1,
"Low-density lipoprotein":1,
"indocyanine green":1,
"photothermal therapy":1,
"silica nanoparticles":1,
"programmed death-ligand 1 (PD-L1)":1,
"Lateral lymph node metastasis":1,
"Skip metastasis":1,
"Calcitonin-negative medullary thyroid carcinoma":1,
"spherule":1,
"COL5A1":1,
"circRNA ACAP2":1,
"miR-29a-3p":1,
"miR-29b-3p":1,
"RECIST":1,
"doubling time":1,
"lung metastases":1,
"Levothyroxine":1,
"SREBP1":1,
"FT-IR":1,
"Multivariate analysis":1,
"Monoclonal PAX8":1,
"PAX8 antibody":1,
"Chicken chorioallantoic membrane":1,
"Combination chemotherapy":1,
"Fingolimod":1,
"Folate receptor":1,
"Mesoporous silica nanoparticles":1,
"Methotrexate":1,
"Surface functionalization":1,
"Targeted drug delivery":1,
"BACH2":1,
"Exosomes":1,
"Kras":1,
"Necroptosis":1,
"miR-146/miR-210":1,
"Cell phone":1,
"Genetic susceptible":1,
"Genetic-environment interaction":1,
"Radiofrequency radiation":1,
"C cell hyperplasia":1,
"C cells":1,
"Calcitonin":1,
"HRD1":1,
"SIRT2":1,
"histone deacetylase":1,
"4D-CT":1,
"dual-energy CT":1,
"quantitative information":1,
"mimic":1,
"plasmacytoma":1,
"pancreas":1,
"synchronous tumour":1,
"international experience":1,
"natural orifice transluminal endoscopic surgery":1,
"remote access surgery":1,
"transoral thyroid surgery":1,
"Cervical embryonal rhabdomyosarcoma":1,
"DICER1-related multinodular goiter":1,
"Ovarian sex-cord stromal tumors":1,
"Pleuropulmonary blastoma":1,
"Sertoli-Leydig cell tumors of the ovary":1,
"Tumor suppressor":1,
"nodule":2,
"risk":1,
"stratification":1,
"TIR3B":1,
"Agricultural workers":1,
"DNA damage":1,
"Farmworkers":1,
"Pesticide exposure":1,
"Synthetic pesticides":1,
"cancer survivorship":1,
"cardiovascular diseases":1,
"cause of death":1,
"neoplasms":2,
"noncancer mortality":1,
"suicide":1,
"health care":1,
"high-volume hospitals":1,
"quality indicators":1,
"quality of care":1,
"Blood analysis":1,
"Silver nanoparticles":1,
"Surface-enhanced Raman spectroscopy":1,
"Surgery assessment":1,
"Diffusion magnetic resonance imaging":1,
"Reproducibility of results":1,
"Clinical":1,
"Grade":1,
"Primary":1,
"1,25-Dihydroxy vitamin D3 [1,25-(OH)(2)D(3)]":1,
"Ras-MEK-ERK pathway":1,
"Right paraesophageal lymph node":1,
"SCARA5":1,
"HK2":1,
"Resibufogenin":1,
"Warburg effect":1,
"miR-143-3p":1,
"Molecular genetics":1,
"Remission":1,
"cribriform–morular variant":1,
"familial adenomatous polyposis":1,
"Candidate genes":1,
"Hereditary papillary thyroid carcinoma":1,
"Inherited predisposition":1,
"Whole exome sequencing":1,
"PTEN":1,
"miR-552":1,
"tumor-initiating cells":1,
"TLR4":1,
"ceRNAs":1,
"circFNDC3B":1,
"miR-1178":1,
"FSCN1":1,
"Methylation":1,
"Promoter":1,
"cytokine":1,
"immune-related adverse events":1,
"thyroid dysfunction":1,
"Radiofrequency ablation":2,
"Thyrogen":1,
"Thyroxine":1,
"HPV (human papilloma virus)":1,
"Lymphadenopathy":1,
"Metastasis of unknown primary":1,
"Disease-specific survival":1,
"SEER database":2,
"elderly people":1,
"SEER Program":1,
"da Vinci SP robotic system":1,
"robotic surgery":1,
"transaxillary":1,
"Age at diagnosis":1,
"Tumor size":1,
"polygenic risk score":1,
"risk prediction":1,
"autoantibody":1,
"Gallium":1,
"Lutetium":1,
"Prostate-specific membrane antigen":1,
"Radioactive iodine-refractory differentiated thyroid carcinoma":1,
"Theranostic":1,
"Asphyxia":1,
"Cultured cell":1,
"Ischemia/hypoxia":1,
"Lupus erythematosus, systemic":1,
"VE1":1,
"immune/chemotherapy":1,
"lung squamous cell carcinoma":1,
"Carcinoma larynx":1,
"Contrast enhanced CT":1,
"Total laryngectomy":1,
"Disease gene prediction":1,
"Ensemble learning":1,
"Network centrality":1,
"Protein-protein interaction network":1,
"Sample-based networks":1,
"WGCNA":1,
"Inflammatory markers":1,
"estrogen receptor alpha, NR2F2, cistrome, active histone modifications, chromatin interactions, breast cancer, luminal A subtype":1,
"autophagy":1,
"sanguinarine":1,
"CVID":1,
"common variable immunodeficiency":1,
"lymphoproliferation":1,
"lymphoproliferative disease":1,
"lymphoproliferative disorder":1,
"Polymerase chain reaction":1,
"131I-SPECT/CT":1,
"131I-whole body scan (WBS)":1,
"Differentiated thyroid carcinoma (DTC)":3,
"Long-term follow-up":1,
"Neck lymph node metastases":1,
"Papillary carcinoma of thyroid":1,
"Voice Handicap Index":1,
"Voice change after thyroidectomy":1,
"Weight and volume of thyroid gland":1,
"Carcinoma thyroid":1,
"Laryngeal resection":1,
"Tracheal resection":1,
"Genome":1,
"High-throughput nucleotide sequencing":1,
"Thyroid carcinoma, anaplastic":1,
"Transcriptome":1,
"Richter’s syndrome":1,
"chronic lymphocytic leukemia":1,
"liver":1,
"Acellular dermis":1,
"Breast reconstruction":1,
"Breast-conserving surgery":1,
"Collision carcinoma":1,
"Laryngeal carcinoma":1,
"Neuroendocrine carcinoma":1,
"Squamous cell carcinoma":2,
"Extra-mammary":1,
"Intraductal lesion":1,
"Male breast cancer":1,
"Ureteral cancer":1,
"occupational exposure":1,
"OTUD6B-AS1":1,
"miR-183-5p":1,
"miR-21":1,
"Oral metastatic carcinoma":1,
"Oral soft tissue":1,
"cellularity":1,
"next-generation sequencing (NGS)":1,
"nucleic acid quality":1,
"nucleic acid yield":1,
"storage time":1,
"Glucocorticoids":1,
"Hypoparathyroidism":1,
"Da Vinci robotic surgical system":1,
"Retroauricular approach":1,
"Accuracy":1,
"gender":1,
"PAX-8":1,
"dedifferentiated squamous cell carcinoma":1,
"tall cell variant":1,
"CVVHD":1,
"continuous venovenous hemodialysis":1,
"giant parathyroid adenoma":1,
"Radiation therapy":1,
"Insular carcinoma":1,
"Poorly differentiated thyroid carcinoma":1,
"Turin proposal":1,
"thyroid imaging reporting and data systems":1,
"ultrasound examination":1,
"Chemo-resistance":1,
"diabetes mellitus":1,
"mendelian randomization":1,
"molecular epidemiology":1,
"type 2":1,
"diagnostic accuracy":1,
"lateral neck metastasis":1,
"Thyroglossal duct neoplasms":1,
"thyroglossal duct remnant":1,
"ROCK1":1,
"malignant proliferation and diffusion":1,
"miR-135a":1,
"non-small cell lung carcinoma":1,
"vitamin D":1,
"vitamin D receptor":1,
"RNA targeted sequencing":1,
"fusion genes":1,
"pediatric":1,
"rearrangements":1,
"Ovarian toxicity":1,
"Liver metastasis":1,
"Liver surgery":1,
"K-TIRADS":1,
"isthmic":1,
"high risk":1,
"predictive factors":1,
"Cystic lesion":1,
"Lateral neck dissection":1,
"Scarless endoscopic thyroidectomy":1,
"NF1 gene":1,
"RET proto-oncogene":1,
"children":2,
"vandetanib":1,
"Cell Biology":1,
"Molecular Biology":1,
"adrenal cancer":1,
"pathways":1,
"standard operating procedures":1,
"targeted therapies":1,
"Adipokines":1,
"IL-6":1,
"Leptin":1,
"TNF-α":1,
"central lymph node metastasis":1,
"elderly patients":1,
"micro-carcinoma":1,
"Anaplastic":1,
"Squamous":1,
"Betulinic acid":1,
"Cell proliferation and migration":1,
"Gastric cancer":1,
"NF-κB":1,
"VASP":1,
"Positive tumor margin":1,
"Relapse-free survival":1,
"Surveillance, Epidemiology, and End Results (SEER)":1,
"synergic effect":1,
"Kelch-like ECH-associated protein 1 (Keap1)":1,
"Nfe2l2":1,
"RNA-Seq":1,
"immune response":1,
"iodine":1,
"TC":1,
"TF-Ab":1,
"TF-Ag":1,
"Thomsen–Friedenreich antibody":1,
"Thomsen–Friedenreich antigen":1,
"mAb A78-G/A7":1,
"Non-coding RNA":1,
"Receptors":1,
"Immune infiltration":1,
"Tumor mutation burden (TMB)":1,
"FAM172A":1,
"follicular thyroid adenoma":1,
"juvenile":1,
"Notch signaling":1,
"invasion and migration":1,
"semaphorin 6B":1,
"Expression profile":1,
"ANGPTL2":1,
"CSN5":1,
"PGT-M":1,
"assisted reproductive technology":1,
"multiple endocrine neopasia type 2":1,
"rearranged during transfection (RET)":1,
"β-elemene":1,
"PET‐CT":1,
"fine‐needle biopsy":1,
"ACC, adrenocortical carcinoma":1,
"BLCA, bladder urothelial carcinoma":1,
"BRCA, breast invasive carcinoma":1,
"CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma":1,
"CHOL, cholangiocarcinoma":1,
"COAD, colon adenocarcinoma":1,
"Cancer therapy":1,
"DLBC, lymphoid neoplasm diffuse large B-cell lymphoma":1,
"ESCA, esophageal carcinoma":1,
"GBM, glioblastoma multiforme":1,
"HNSC, head and neck squamous cell carcinoma":1,
"KICH, kidney chromophobe":1,
"KIRC, kidney renal clear cell carcinoma":1,
"KIRP, kidney renal papillary cell carcinoma":1,
"LAML, acute myeloid leukemia":1,
"LGG, brain lower grade glioma":1,
"LIHC, liver hepatocellular carcinoma":1,
"LUAD, lung adenocarcinoma":1,
"LUSC, lung squamous cell carcinoma":1,
"MESO, mesothelioma":1,
"OV, ovarian serous cystadenocarcinoma":1,
"PAAD, pancreatic adenocarcinoma":1,
"PCPG, pheochromocytoma and paraganglioma":1,
"PRAD, prostate adenocarcinoma":1,
"Pan-cancer analysis":1,
"READ, rectum adenocarcinoma":1,
"RNA interaction":1,
"SARC, sarcoma":1,
"SKCM, skin cutaneous melanoma":1,
"STAD, stomach adenocarcinoma":1,
"Synthetic lethality":1,
"TGCT, testicular germ cell tumors":1,
"THCA, thyroid carcinoma":1,
"THYM, thymoma":1,
"TSG, tumor suppressor gene":1,
"UCEC, uterine corpus endometrial carcinoma":1,
"UCS, uterine carcinosarcoma":1,
"UVM, uveal melanoma":1,
"Cystadenocarcinoma":1,
"Cystadenoma":1,
"Mesenteric cyst":1,
"Mesentery":1,
"Mesocolon":1,
"retropharyngeal space":1,
"well-differentiated thyroid cancer":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年第1季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
